James Mond
2016
In 2016, James Mond earned a total compensation of $511.2K as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 31% decrease compared to previous year.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $20,606 |
| Salary | $360,177 |
| Other | $7,950 |
| Total | $511,233 |
Mond received $360.2K in salary, accounting for 70% of the total pay in 2016.
Mond also received $122.5K in bonus, $20.6K in option awards and $8K in other compensation.
Rankings
In 2016, James Mond's compensation ranked 11,100th out of 14,075 executives tracked by ExecPay. In other words, Mond earned more than 21.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,100 out of 14,075 | 21st |
Division Manufacturing | 4,312 out of 5,489 | 21st |
Major group Chemicals And Allied Products | 1,536 out of 1,895 | 19th |
Industry group Drugs | 1,238 out of 1,538 | 20th |
Industry Biological Products, Except Diagnostic Substances | 217 out of 279 | 22nd |
Source: SEC filing on April 27, 2018.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2016.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019